Table 1.

Prevalence of HPV DNA by cytologic findings among 969 women, Ulaanbaatar, Mongolia, 2005

HPV typeCytology
Normal
Abnormal
Total
SingleMultipleTotal (%)SingleMultipleTotal (%)SingleMultipleTotal (%)
Negative585 (69.5)45 (35.4)630 (65.0)
Positive154103257 (30.5)424082* (64.6)196143339 (35.0)
High risk7893171 (20.3)293766 (52.0)107130237 (24.5)
Low risk6872140 (16.6)112738 (29.9)7999178 (18.4)
Uncharacterized88 (1.0)22 (1.6)1010 (1.0)
High risk
    16132740 (4.8)91019 (15.0)223759 (6.1)
    1881220 (2.4)044 (3.2)81624 (2.5)
    31111728 (3.3)1178 (6.3)122436 (3.7)
    336814 (1.7)3710 (7.9)91524 (2.5)
    3541115 (1.8)1910 (7.9)52025 (2.6)
    39639 (1.1)123 (2.4)7512 (1.2)
    4551520 (2.4)011 (0.8)51621 (2.2)
    5151015 (1.8)268 (6.3)71623 (2.4)
    5211213 (1.5)459 (7.1)51722 (2.3)
    5641317 (2.0)033 (2.4)41620 (2.1)
    5841216 (1.9)459 (7.1)81725 (2.6)
    59257 (0.8)325 (3.9)5712 (1.2)
    68022 (0.2)000 (0.0)022 (0.2)
    7371320 (2.4)123 (2.4)81523 (2.4)
    82279 (1.1)022 (1.6)2911 (1.1)
Low risk
    6134 (0.5)112 (1.6)246 (0.6)
    115510 (1.2)224 (3.2)7714 (1.4)
    26235 (0.6)022 (1.6)257 (0.7)
    30202 (0.2)022 (1.6)224 (0.4)
    32101 (0.1)000 (0.0)101 (0.1)
    40145 (0.6)022 (1.6)167 (0.7)
    4261016 (1.9)167 (5.5)71623 (2.4)
    43257 (0.8)112 (1.6)369 (0.9)
    53123 (0.4)123 (2.4)246 (0.6)
    54246 (0.7)000 (0.0)246 (0.6)
    55415 (0.6)022 (1.6)437 (0.7)
    66121325 (3.0)156 (4.7)131831 (3.2)
    67268 (1.0)033 (2.4)2911 (1.1)
    7061420 (2.4)145 (3.9)71825 (2.6)
    8171320 (2.4)235 (3.9)91625 (2.6)
    83246 (0.7)044 (3.2)2810 (1.0)
Jc971011920 (2.4)055 (3.9)111425 (2.6)
Cp6108156 (0.7)101 (0.8)257 (0.7)
  • * Including six cervical intraepithelial lesions grade 3/carcinoma in situ (3x HPV16, HPV33, HPV35, and HPV35/53/66) and two invasive cervical cancers (HPV16 and HPV16/33).